- Home
- LGL vs LVTX Comparison
LGL vs LVTX Comparison
Compare LGL & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGL
- LVTX
- Stock Information
- Founded
- LGL 1917
- LVTX 2016
- Country
- LGL United States
- LVTX Netherlands
- Employees
- LGL N/A
- LVTX N/A
- Industry
- LGL Industrial Machinery/Components
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- LGL Technology
- LVTX Health Care
- Exchange
- LGL Nasdaq
- LVTX Nasdaq
- Market Cap
- LGL 35.6M
- LVTX 33.9M
- IPO Year
- LGL N/A
- LVTX 2021
- Fundamental
- Price
- LGL $7.23
- LVTX $1.31
- Analyst Decision
- LGL
- LVTX Hold
- Analyst Count
- LGL 0
- LVTX 3
- Target Price
- LGL N/A
- LVTX $1.75
- AVG Volume (30 Days)
- LGL 37.2K
- LVTX 34.5K
- Earning Date
- LGL 08-12-2025
- LVTX 08-19-2025
- Dividend Yield
- LGL N/A
- LVTX N/A
- EPS Growth
- LGL 204.51
- LVTX N/A
- EPS
- LGL 0.08
- LVTX N/A
- Revenue
- LGL $4,322,000.00
- LVTX $4,990,000.00
- Revenue This Year
- LGL N/A
- LVTX N/A
- Revenue Next Year
- LGL N/A
- LVTX N/A
- P/E Ratio
- LGL $94.50
- LVTX N/A
- Revenue Growth
- LGL 20.66
- LVTX N/A
- 52 Week Low
- LGL $4.91
- LVTX $0.85
- 52 Week High
- LGL $9.74
- LVTX $2.39
- Technical
- Relative Strength Index (RSI)
- LGL 60.84
- LVTX 49.61
- Support Level
- LGL $5.88
- LVTX $1.28
- Resistance Level
- LGL $9.74
- LVTX $1.38
- Average True Range (ATR)
- LGL 0.87
- LVTX 0.05
- MACD
- LGL 0.05
- LVTX -0.00
- Stochastic Oscillator
- LGL 34.97
- LVTX 26.92
About LGL LGL Group Inc. (The)
LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.